RhumbLine Advisers’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.78M Buy
362,055
+34,453
+11% +$236K ﹤0.01% 1686
2025
Q4
$649K Buy
327,602
+12,979
+4% +$29.4K ﹤0.01% 2500
2025
Q3
$774K Sell
314,623
-19,934
-6% -$51.3K ﹤0.01% 2402
2025
Q2
$883K Buy
334,557
+115,197
+53% +$310K ﹤0.01% 2310
2025
Q1
$660K Buy
219,360
+11,573
+6% +$35.1K ﹤0.01% 2385
2024
Q4
$532K Buy
207,787
+299
+0.1% +$1.25K ﹤0.01% 2644
2024
Q3
$772K Sell
207,488
-4,189
-2% -$19.4K ﹤0.01% 2405
2024
Q2
$1.34M Buy
211,677
+24,802
+13% +$164K ﹤0.01% 2087
2024
Q1
$1M Buy
186,875
+8,035
+4% +$36.4K ﹤0.01% 2245
2023
Q4
$898K Buy
178,840
+37,045
+26% +$116K ﹤0.01% 2317
2023
Q3
$240K Sell
141,795
-5,350
-4% -$10.7K ﹤0.01% 3056
2023
Q2
$409K Buy
147,145
+35,371
+32% +$100K ﹤0.01% 2820
2023
Q1
$203K Sell
111,774
-830
-0.7% -$2.58K ﹤0.01% 2738
2022
Q4
$571K Buy
112,604
+3,077
+3% +$16.9K ﹤0.01% 2401
2022
Q3
$544K Buy
109,527
+8,495
+8% +$38.7K ﹤0.01% 2461
2022
Q2
$376K Buy
101,032
+12,909
+15% +$51.9K ﹤0.01% 2634
2022
Q1
$494K Sell
88,123
-2,155
-2% -$13.2K ﹤0.01% 2432
2021
Q4
$549K Sell
90,278
-2,130
-2% -$16K ﹤0.01% 2467
2021
Q3
$900K Buy
92,408
+3,268
+4% +$36K ﹤0.01% 2272
2021
Q2
$1.27M Buy
89,140
+51,249
+135% +$847K ﹤0.01% 2140
2021
Q1
$900K Sell
37,891
-2,437
-6% -$63.2K ﹤0.01% 2229
2020
Q4
$538K Buy
40,328
+3,170
+9% +$30.5K ﹤0.01% 2411
2020
Q3
$258K Buy
37,158
+259
+0.7% +$2.58K ﹤0.01% 2583
2020
Q2
$453K Buy
+36,899
New +$208K ﹤0.01% 2396
2019
Q2
Sell
-38,052
Closed -$60K 2987
2019
Q1
$60K Sell
38,052
-190
-0.5% -$239 ﹤0.01% 2908
2018
Q4
$44K Buy
38,242
+9,570
+33% +$21.9K ﹤0.01% 2951
2018
Q3
$106K Buy
28,672
+150
+0.5% +$474 ﹤0.01% 2860
2018
Q2
$87K Buy
28,522
+44
+0.2% +$163 ﹤0.01% 2884
2018
Q1
$111K Sell
28,478
-1,040
-4% -$4.56K ﹤0.01% 2729
2017
Q4
$133K Sell
29,518
-5,491
-16% -$26K ﹤0.01% 2731
2017
Q3
$192K Buy
35,009
+220
+0.6% +$1.36K ﹤0.01% 2751
2017
Q2
$264K Buy
34,789
+20,646
+146% +$89.2K ﹤0.01% 2623
2017
Q1
$50K Sell
14,143
-2,459
-15% -$12.2K ﹤0.01% 2825
2016
Q4
$95K Buy
16,602
+737
+5% +$4.92K ﹤0.01% 2797
2016
Q3
$123K Buy
15,865
+400
+3% +$2.99K ﹤0.01% 2786
2016
Q2
$96K Buy
+15,465
New +$120K ﹤0.01% 2918

Other funds holding IBRX